AKT1 and ovarian carcinoma: Most cases of ovarian cancer, however, occur further upstream via hyperactivation of the phosphoinositol 3 kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway as shown in Figure 2.